Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-22.47	21.30	27.47
Graham Fair Price	-19.18	117808.69	145762.14
PEG	6320.67	-0.21	< 0.005
Price/Book	-4.07	0.26	0.27
Price/Cash Flow	-1035.11	-170.91	-15.06
Prices/Earnings	52.86	7.47	4.88
Price/Sales	-7.06	0.58	0.63
Price/FCF	-1035.11	-170.91	-15.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	7.65	0.19	0.17
Operating Margin	50.89	0.06	0.04
ROA	-37.81	< 0.005	< 0.005
ROE	0.01	< 0.005	-37.24
ROIC	< 0.005	0.01	53.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.10	-0.10	-3.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.34	0.59	-56.12
EPS QOQ	15.11	-0.36	-97.62
FCF QOQ	-1.68	0.91	-45.51
Revenue QOQ	0.11	0.05	-51.96
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.56	62.02	-2.41
Days Sales Outstanding (DSO)	49.22	45.43	-7.69
Inventory Turnover	1.42	1.45	2.47
Debt/Capitalization	0.41	0.43	4.62
Quick Ratio	0.54	1.19	120.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	262047.31	377449.35	44.04
Cash	24422.10	33533.75	37.31
Capex	-4831.79	4746.11	-1.77
Free Cash Flow	-4675.72	-403.14	91.38
Revenue	112558.22	118528.91	5.30
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.43	1.65	15.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.21	15.25	-20.64
Naive Interpretation	Member

06 - Financial Health · Weak

Rating